Check-Cap Ltd. (MBAI) Fair Value 2026

MBAI · X-Ray Apparatus & Tubes & Related Irradiation Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.3 /10

32 fundamental signals · 12 models active

Value Trap Risk

(—/100)

Quick Summary — As of 2026-07-14, Check-Cap Ltd. (MBAI) trades at $1.13, approximately 198% above CirclFi’s Bayesian DCF fair value of $0.38. QOC: 2.3/10. 12/13 models active.

Key Facts

Ticker
MBAI
Price
$1.13
Quality Score
2.3/10
Value Trap Risk
—/100
Models Active
12/13
Last Updated
Strength: Earnings Power Value suggests +423.3% upside with 37% confidence
Risk: Below-average Quality Score of 2.3/10 signals weak fundamentals

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($1.13)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
$0.38 -66.4%
Earnings Power Value
Medium Conviction
$5.91 +423.3%
CUCE Ensemble
Low Conviction
$0.80 -29.5%
First Chicago
Low Conviction
$2.02 +78.7%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is Check-Cap Ltd. (MBAI) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Check-Cap Ltd.'s intrinsic value is estimated at $1.75, suggesting a +54.7% average upside from the current price of $1.13. While 7 models see room for appreciation, model agreement is not unanimous as 5 models flag potential overvaluation. Model dispersion is worth noting: EPV targets $5.91 (+423.3%), versus Dynamic NAV at $0.25 (-78.3%). This +501.6% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About MBAI?

12 of 13 models are currently active for MBAI. Of these, 7 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates MBAI's intrinsic value at $0.38, implying -66.4% downside from the current price. See which stocks rank higher →

How Does MBAI Rank in X-Ray Apparatus & Tubes & Related Irradiation Apparatus?

Among 5 X-Ray Apparatus & Tubes & Related Irradiation Apparatus stocks, MBAI ranks #5 by Quality of Company score. CirclFi's QOC score of 2.3/10 evaluates 32 fundamental signals. A score of 2.3 signals below-average fundamentals.

Check-Cap Ltd. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is MBAI a Value Trap?

The Value Trap algorithm is not active for MBAI. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Check-Cap Ltd.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Check-Cap Ltd. is rated at 2.3/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.

The gap between the most bullish and bearish model spans +501.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MBAI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MBAI's 12 active models, average confidence is 18%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Check-Cap Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar X-Ray Apparatus & Tubes & Related Irradiation Apparatus Stocks Should You Also Analyze?

4 related X-Ray Apparatus & Tubes & Related Irradiation Apparatus stocks with 13-model coverage

Read investment analysis: GEHC · BFLY · PHG · NNOX

Frequently Asked Questions About Check-Cap Ltd.

What is Check-Cap Ltd.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Check-Cap Ltd. (MBAI) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.38. The Quality of Company score is 2.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MBAI overvalued or undervalued right now?

At $1.13, 7 of 12 active models suggest MBAI may be undervalued, while 5 indicate potential overvaluation. The assessment depends on which methodology best fits Check-Cap Ltd.'s business model in X-Ray Apparatus & Tubes & Related Irradiation Apparatus.

What does a Quality of Company score of 2.3 mean for MBAI?

Check-Cap Ltd.'s QOC of 2.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on MBAI?

CirclFi analyzes MBAI with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is MBAI a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for MBAI at this time. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on MBAI.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access